Identifying subgroups of ICU patients with high mortality rates using machine learning: A nationwide, population-based study.

Authors

Julian van Gemert, Mark van den Boogaard, Cornelia Hoedemaekers, Hans van der Hoeven, Monika Kerckhoffs, Max Hinne, Nicolette de Keizer, Marieke Zegers

Published in

Journal of critical care. Volume 95. Pages 155669. Jun 27, 2026. Epub Jun 27, 2026.

Abstract

Identifying subgroups of intensive care unit (ICU) patients with high mortality rates can provide directions in policy making about appropriate intensive care medicine. The objective of the study was to identify demographical and clinical characteristics of subgroups of ICU patients with high (≥80%) mortality rates at six months post-ICU admission.
Data from all Dutch ICU patients admitted between 2013 and 2023 are used. Data are obtained from the Dutch National Intensive Care Evaluation (NICE) registry, including 807,727 ICU admissions from 84 hospitals. A machine learning model was trained on four samples, defined at different stages of the ICU admission with varying amounts of available data. Training was performed on 70% of the hospitals and validation on the other 30% for the years 2013-2022. A temporal validation was performed on data from 2023.
Ten high-mortality subgroups were identified. Reduced urine output and a low combined score on the eye & motor components of the Glasgow Coma Scale (GCS) were the most common risk factors defining high-mortality subgroups. External validation showed small deviations in mortality (median absolute deviations -1% and -2%), with one subgroup falling below the 80% mortality threshold.
Interpretable machine learning can identify ICU patient subgroups with ≥80% 6-month mortality using routinely collected data. These groups are predominantly marked by impaired consciousness and reduced urine output. Future work should integrate these insights into ethical, patient-centered frameworks that support appropriate care.

PMID:
42364273
Bibliographic data and abstract were imported from PubMed on 28 Jun 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.